Delivery Order SPE2DB22D3004-SPE2DB25FRA70
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 6, 2025, with a ceiling value of $2,586.96 and a completion date of February 7, 2025. The contract is a delivery order with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds an...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,625.81 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets in quantities of 30s. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price of $4,452.96 and a completion date of June 9, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp is the...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,940.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 6, 2025. The contract has a completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $6,905.01 and is a Firm Fixed Price Delivery Order with a completion date of May 30, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and was awarded on May 29, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets (30 count) to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,586.96 and a completion date of January 30, 2025. The contract was awarded on January 29, 2025 and does not have a...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 4 mg tablets. The contract, valued at $13,603.15, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract award is for the delivery of Ondansetron ODT 4 mg tablets in quantities of 30s, with a ceiling value of $22,423.13 and an ultimate completion date of February 6, 2025. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed-price pricing type, and there was no set-aside designation used. Amerisourcebergen...
This federal contract award is for the delivery of ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company that is a subsidiary of the parent company Cencora, Inc. The total ceiling value of the contract is $1,327.99, with a period of performance through April 25, 2023. This is a Firm Fixed Price Delivery Order contract, without any set-aside...
This federal contract award is for the delivery of 4,564,662,850 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $5,905.15 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024, with a completion date of May 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...